Medicare Enrolled

Dr. Joseph Hagman, MD

Radiation Oncology · Flower Mound, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
4001 LONG PRAIRIE RD, Flower Mound, TX 75028
9728743900
In practice since 2006 (19 years)
NPI: 1225095037 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hagman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hagman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hagman

Dr. Joseph Hagman is a radiation oncology in Flower Mound, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hagman performed 560 Medicare services across 316 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hagman received a total of $11,002 from 6 pharmaceutical and/or device companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hagman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 560 Medicare services$ $11,002 industry payments

Medicare Practice Summary

Medicare Utilization ↗
560
Medicare services
Bottom 22% in TX for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
316
Unique beneficiaries
$423
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Ultrasound study of arm or leg veins with compression and maneuvers160$136$553
Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance130$807$4,053
Laser destruction of incompetent vein of arm or leg using imaging guidance90$748$3,200
Ultrasound study of one arm or leg veins with compression and maneuvers85$88$342
Injection of chemical agent into multiple incompetent veins of leg34$141$543
Injection of chemical agent into single incompetent vein of leg using ultrasound guidance27$1,023$4,374
New patient office visit (45-59 min)19$128$460
Office visit, established patient (10-19 min)15$40$127
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,002
Total received (2018-2024)
Avg $1,572/year across 7 years
Top 6% in TX for radiation oncology
6
Companies
51
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$9,751 (88.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$920 (8.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$331 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,591
2023
$2,881
2022
$51
2021
$68
2020
$146
2019
$201
2018
$63

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$9,751
Medtronic, Inc.
$656
Tactile Systems Technology Inc
$425
Boston Scientific Corporation
$104
Medtronic Vascular, Inc.
$50
CashFlow Solutions, LLC
$16
Top 3 companies account for 98.5% of total payments
Associated products mentioned in payments ›
CLOSUREFAST · ClosureFast · FLEXITOUCH · Flexitouch Plus · INTELLIS ADAPTIVESTIM · LYMPHA PRESS OPTIMAL PLUS(US) BT · VENACURE 1470 PRO · VENASEAL · Varithena Administration Pack · VenaCure 1470 Pro · VenaSeal
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 6% for radiation oncology in TX.

Equivalent to $1,965 per 100 Medicare services performed
Looking for a radiation oncology in Flower Mound?
Compare radiation oncologys in the Flower Mound area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologys nearby

Geographic Context

Radiation Oncologys within 10 mi
583
Per 100K population
61.7
County median income
$108,185
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL FLOWER MOUND
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hagman is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hagman experienced with ultrasound study of arm or leg veins with compression and maneuvers?
Based on Medicare claims data, Dr. Hagman performed 160 ultrasound study of arm or leg veins with compression and maneuvers services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hagman receive payments from pharmaceutical companies?
Yes. Dr. Hagman received a total of $11,002 from 6 companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hagman's costs compare to other radiation oncologys in Flower Mound?
Dr. Hagman's average Medicare payment per service is $423. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hagman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →